ADN(ADN)
ADN
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E |
|---|---|
| Revenue Avg | $395M |
| Low | $395M |
| High | $395M |
| EBITDA Avg | $-395M |
| Low | $-395M |
| High | $-395M |
| EBIT Avg | $-395M |
| Low | $-395M |
| High | $-395M |
| Net Income Avg | $103M |
| Low | $103M |
| High | $103M |
| EPS Avg | $39.39 |
| Low | $39.39 |
| High | $39.39 |
| Analysts (Rev / EPS) | 1 / 1 |